Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ERG | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | PRPF3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | LATS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | NOC2L | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | GPR19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | RCOR2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | CDKN1B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | OLFM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GNRH1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | LDHD | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |